TrialAmerican journal of hematology2017
An exploratory clinical trial of bortezomib in patients with lower risk myelodysplastic syndromes.
May Daher et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papercites it